Michael Douglas Taylor - Net Worth and Insider Trading

Michael Douglas Taylor Net Worth

The estimated net worth of Michael Douglas Taylor is at least $0 dollars as of 2024-04-29. Michael Douglas Taylor is the Director of Deciphera Pharmaceuticals Inc and owns about 0 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $0. Details can be seen in Michael Douglas Taylor's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Douglas Taylor has not made any transactions after 2021-04-01 and currently still holds the listed stock(s).

Transaction Summary of Michael Douglas Taylor

To

Michael Douglas Taylor Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Douglas Taylor owns 2 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) , and Adhera Therapeutics Inc (ATRX) .

Click here to see the complete history of Michael Douglas Taylor’s form 4 insider trades.

Insider Ownership Summary of Michael Douglas Taylor

Ticker Comapny Transaction Date Type of Owner
DCPH Deciphera Pharmaceuticals Inc 2021-04-01 director & See Remarks
ATRX Adhera Therapeutics Inc 2010-07-21 director

Michael Douglas Taylor Latest Holdings Summary

Michael Douglas Taylor currently owns a total of 1 stock. Michael Douglas Taylor owns 0 shares of Deciphera Pharmaceuticals Inc (DCPH) as of April 1, 2021, with a value of $0.

Latest Holdings of Michael Douglas Taylor

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DCPH Deciphera Pharmaceuticals Inc 2021-04-01 0 25.28 0

Holding Weightings of Michael Douglas Taylor


Michael Douglas Taylor Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Douglas Taylor has made a total of 18 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in Deciphera Pharmaceuticals Inc is the sale of 8,000 shares on April 1, 2021, which brought Michael Douglas Taylor around $364,560.

Insider Trading History of Michael Douglas Taylor

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Douglas Taylor Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael Douglas Taylor Ownership Network

Ownership Network List of Michael Douglas Taylor

No Data

Ownership Network Relation of Michael Douglas Taylor


Michael Douglas Taylor Owned Company Details

What does Deciphera Pharmaceuticals Inc do?

Who are the key executives at Deciphera Pharmaceuticals Inc?

Michael Douglas Taylor is the director & See Remarks of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include EVP & Chief Medical Officer Matthew L Sherman , Chief Financial Officer Thomas Patrick Kelly , and Chief Commercial Officer Daniel C. Martin .

Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary

Over the past 18 months, Michael Douglas Taylor made no insider transaction in Deciphera Pharmaceuticals Inc (DCPH). Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 26,559 shares made by Daniel C. Martin , a net sale of 14,587 shares made by Matthew L Sherman , and a net sale of 11,601 shares made by Thomas Patrick Kelly .

In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 154,121 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 1,687,666 shares were bought by its insiders, resulting in a net purchase of 1,533,545 shares.

Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Deciphera Pharmaceuticals Inc Insider Transactions

No Available Data

Michael Douglas Taylor Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Douglas Taylor. You might contact Michael Douglas Taylor via mailing address: C/o Deciphera Pharmaceuticals, Llc, 500 Totten Pond Road, Waltham Ma 02451.

Discussions on Michael Douglas Taylor

No discussions yet.